You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

114 search results for: patient burden

Prurigo Nodularis: The <b>Patient</b> Journey
interactivity

Prurigo Nodularis: The Patient Journey

Dermatology
An interactive tool highlighting the disease burden, impact and management of prurigo nodularis throughout the patient journey before diagnosis, during diagnosis and during treatment.
View more
Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria
expert video

Inside the Hive: Type 2 Inflammatory Pathways in Chronic Spontaneous Urticaria

Dermatology
Join Dr. Jason Hawkes in discussing the burden of CSU and how type 2 inflammation contributes to the development of chronic wheals (hives) and angioedema
View more
Why Is It Important to Assess Lung Function in Pediatric Severe Asthma <b>Patient</b>s?
expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

Pulmonology
Prof. Monika Gappa presents the importance in assessment of lung function in pediatric patients alongside the associated patient burden.
View more
IRS-ISIAN 2024 | The Underappreciated <b>Burden</b> of Smell Loss and Congestion in CRSwNP
expert video

IRS-ISIAN 2024 | The Underappreciated Burden of Smell Loss and Congestion in CRSwNP

Rhinology
Prof. Joaquim Mullol describes the burdens of smell loss and nasal congestion for patients with uncontrolled and/or severe CRSwNP.
View more
EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression
expert video

EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression

Type 2 Inflammation
Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients
View more
CRSwNP Significantly Affects the Quality of Life of CRSwNP <b>Patient</b>s
interactivity

CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients

Rhinology
Explore the factors that contribute to the significant burden of CRSwNP on patient quality of life.
View more
Importance of Lung Function Assessment in Pediatric Asthma <b>Patient</b>s
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Review the burden associated with lung function decline in pediatric patients with severe asthma, and the value of clinical lung function assessments.
View more
Beyond the Signs ​and Symptoms: ​The Developmental <b>Burden</b> of AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
Emerging Therapeutic Landscape and Implications for <b>Patient</b> Management in PN​
expert video

Emerging Therapeutic Landscape and Implications for Patient Management in PN​

Dermatology
A review of disease burden and treatment needs in PN, and how current and emerging therapies can impact patient management.
View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact <b>Patient</b>s?
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Pulmonology
Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
View more
The Disease <b>Burden</b> of AD in Children and the Impact of Type 2 Comorbidities 
expert video

The Disease Burden of AD in Children and the Impact of Type 2 Comorbidities 

Dermatology
Multidimensional disease burden of atopic dermatitis in children from a real-world case study – Presentation from the ADVENT symposium at EAACI 2023.
View more
Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis
expert video

Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis

Type 2 Inflammation
Prof. Stephan Weidinger discusses the impact of type 2 inflammation on disease burden and clinical outcomes in pediatric patients.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PolandChange country/region